AFRM vs REGN · P/E 590, rev $3.22B vs P/E 14, rev $14.34B
Affirm Holdings Inc (AFRM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AFRM and REGN stock pages for the full models.
Not investment advice.